Cell loss the same with standard phaco and MICS

Article

Phacoemulsification performed with a standard technique yields no significant differences in endothelial cell loss or endothelial morphology when compared with the procedure performed by bimanual microincision cataract surgery (MICS), according to the results of a study published in the August issue of the Journal of Cataract and Refractive Surgery.

Phacoemulsification performed with a standard technique yields no significant differences in endothelial cell loss or endothelial morphology when compared with the procedure performed by bimanual microincision cataract surgery (MICS), according to the results of a study published in the August issue of the Journal of Cataract and Refractive Surgery.

Rita Mencucci, MD and co-workers from the Department of Oto-Neuro-Ophthalmological Surgical Sciences Eye Clinic, University of Florence, Florence, Italy, randomized 80 patients into two groups; 40 eyes to undergo standard stop and chop phaco and the other 40 eyes to receive stop and chop phaco with bimanual MICS. Corneal endothelial cell counts, coefficient of variation in cell size, hexagonality and pachymetry were assessed preoperatively and then again one and three months postoperatively.

Preoperatively, the mean cell count for the entire sample was 2,245 cells/mm² ± 37 (SE). The mean count decreased by 102 cells at one month and by 144 at three months. The difference between the standard group and the MICS group was 25 cells at baseline, 19 cells at one month and 19 cells at three months. There were no changes in the coefficient of variation or morphology in the overall sample and the pattern of change did not differ between the two groups. Corneal thickness increased by 10.2 µm in the overall sample and approached baseline values by three months with an increase of 3.4 µm. There was no difference in corneal thickness between the two groups.

The authors concluded that no significant differences could be found in corneal endothelial cell loss or endothelial morphology between the two techniques.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.